Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083 | Director | April 03, 2017 | April 05, 2017 |
| Acadian Asset Management Inc.AAMI · Entity 4180 | Director · 10% owner | June 12, 2026 | June 15, 2026 |
| Bausch & Lomb CorpBLCO · Entity 3756 | Director | May 26, 2026 | May 28, 2026 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL GROUP, INC.
Report date April 03, 2017 · Filed April 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 3,979 |
Reported balance
After 2017-04-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-04-03 · Grant · Acquired 20 · Balance 3,979 F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 4,585 |
Reported balance
After 2017-04-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-04-03 · Grant · Acquired 606 · Balance 4,585 F2: Grant of deferred stock units pursuant to the 2013 Plan. Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. The award includes dividend equivalent rights payable in the form of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG.
F2: Grant of deferred stock units pursuant to the 2013 Plan. Subject to the terms of the 2013 Plan and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. The award includes dividend equivalent rights payable in the form of deferred stock units.
Acadian Asset Management Inc.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,253 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 2,253 · Balance 2,253 F1: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc. F2: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan. F3: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc.
F2: Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan.
F3: On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset Management Inc.
Bausch & Lomb Corp
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 89,823 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 15,842 · Balance 89,823 F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.
Bausch Health Companies Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 440,962 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 10,720 · Balance 440,962 F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer. |
| Common Shares, No Par ValueSEC Table I · non-derivative | IndirectBy Managed Funds | 73,255,869 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 73,255,869 F2: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.
F2: John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BrightSphere Investment Group plc
Report date February 25, 2019 · Filed February 27, 2019
Section 16 reporting ended · disclosed 2019-02-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.001 per shareSEC Table I · non-derivative | IndirectBy Paulson & Co. Inc. | 20,000,552 |
Reported balance
After 2019-02-25 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-02-25 · Purchase · Acquired 14,790,038 · Balance 20,000,552 F1: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.
F2: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2023 Filed May 19, 2023 20:27 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 29,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016304 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,211 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 04, 2023 Filed May 5, 2023 20:29 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014705 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,613 F1 · shares: Reflects the annual grant of restricted stock units ("RSUs") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders. Read SEC document |
| May 01, 2023 Filed May 2, 2023 20:03 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | GrantRestricted Stock Units · Derivative | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001748824-23-000025 · wf-form4_168305778945045.xml · derivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,334 Underlying: Common Stock · 8,334 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc. F2 · shares: Consists of restricted stock units issued under the BrightSphere Investment Group Inc. Non-Employee Directors' Equity Incentive Plan. F3 · derivative.exercise_date: The restricted stock units vest upon the earlier of June 8, 2023 and the date of the 2023 annual meeting of stockholders of BrightSphere Investment Group Inc. F3 · derivative.expiration_date: The restricted stock units vest upon the earlier of June 8, 2023 and the date of the 2023 annual meeting of stockholders of BrightSphere Investment Group Inc. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 22:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,716 | $8.10 | $62,499.60 |
DisclosureSEC source: 0001127602-23-012411 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,006 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:22 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 1,256 | $17.41 | $21,866.96 |
DisclosureSEC source: 0001127602-23-012204 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,756 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:04 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 9,952 | $6.28 | $62,498.56 |
DisclosureSEC source: 0001127602-23-000168 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,290 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 21:15 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 9,071 | $6.89 | $62,499.19 |
DisclosureSEC source: 0001127602-22-023292 · form4a.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,338 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:46 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,732 | $6.89 | $18,823.48 |
DisclosureSEC source: 0001127602-22-023267 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,999 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 23:28 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 2,251 | $8.36 | $18,818.36 |
DisclosureSEC source: 0001127602-22-018840 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,267 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 20:51 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 34,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-018209 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,016 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| May 10, 2022 Filed May 12, 2022 23:37 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017854 · doc4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the "Company"). F2 · shares: The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:53 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,340 | $22.85 | $30,619.00 |
DisclosureSEC source: 0001127602-22-011284 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,629 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,109 | $27.61 | $30,619.49 |
DisclosureSEC source: 0001127602-22-000095 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,289 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:46 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,099 | $27.85 | $30,607.15 |
DisclosureSEC source: 0001127602-21-026454 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,180 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:13 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,044 | $29.32 | $30,610.08 |
DisclosureSEC source: 0001127602-21-021229 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,081 F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| April 30, 2021 Filed May 3, 2021 20:09 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 7,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014911 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,037 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 21:14 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 952 | $31.74 | $30,216.48 |
DisclosureSEC source: 0001127602-21-012752 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,392 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 23:56 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,442 | $20.80 | $29,993.60 |
DisclosureSEC source: 0001127602-21-000248 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,440 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:02 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,930 | $15.54 | $29,992.20 |
DisclosureSEC source: 0001127602-20-026308 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,998 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 1,545 | $18.29 | $28,258.05 |
DisclosureSEC source: 0001127602-20-020914 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,068 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 21:46 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | SaleCommon Stock, par value $0.001 per share | 647,263 | $9.79 | $6,336,704.77 |
DisclosureSEC source: 0001013594-20-000562 · form4.xml · nonDerivative · entry 2 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Paulson & Co. Inc. Disclosed balance after: 20,000,552 F1 · security: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.direct: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. F3 · ownership.direct: Represent rebalancing transactions between the Funds. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 21:46 UTC | Acadian Asset Management Inc. BSIG · Entity 4180 | PurchaseCommon Stock, par value $0.001 per share | 647,263 | $9.79 | $6,336,704.77 |
DisclosureSEC source: 0001013594-20-000562 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Paulson & Co. Inc. Disclosed balance after: 20,647,815 F1 · security: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.direct: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. F3 · ownership.direct: Represent rebalancing transactions between the Funds. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 585,100 | $15.92 | $9,314,792.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 12 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 25,839,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 624,900 | $15.87 | $9,917,163.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 11 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 25,253,935 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 70,000 | $15.65 | $1,095,500.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 10 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,629,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 14, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 348,920 | $15.85 | $5,530,382.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 9 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,559,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 645,844 | $16.70 | $10,785,594.80 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 8 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 24,210,115 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 80,300 | $16.58 | $1,331,374.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 7 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 23,564,271 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 13, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 603,900 | $16.32 | $9,855,648.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 6 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 23,483,971 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 799,900 | $17.24 | $13,790,276.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 5 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 22,880,071 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 678,400 | $17.47 | $11,851,648.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 4 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 22,080,171 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 374,836 | $17.33 | $6,495,907.88 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 3 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 21,401,771 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 162,900 | $17.50 | $2,850,750.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 2 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 21,026,935 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 12, 2020 Filed May 14, 2020 22:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | PurchaseCommon Stock, no par value | 25,000 | $17.30 | $432,500.00 |
DisclosureSEC source: 0001013594-20-000496 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 20,864,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. Read SEC document |
| May 01, 2020 Filed May 1, 2020 20:23 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 11,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015034 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,523 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:26 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,774 | $15.50 | $27,497.00 |
DisclosureSEC source: 0001127602-20-012705 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,486 Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 21:34 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 919 | $29.92 | $27,496.48 |
DisclosureSEC source: 0001127602-20-000176 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,712 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:39 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,258 | $21.85 | $27,487.30 |
DisclosureSEC source: 0001127602-19-029780 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,793 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,090 | $25.22 | $27,489.80 |
DisclosureSEC source: 0001127602-19-023537 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,535 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 03, 2019 Filed May 3, 2019 20:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 10,633 | $23.51 | $249,981.83 |
DisclosureSEC source: 0001127602-19-017266 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,445 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Bausch Health Companies Inc. ("Bausch Health") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health. Read SEC document |
| March 29, 2019 Filed Apr 3, 2019 20:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,113 | $24.70 | $27,491.10 |
DisclosureSEC source: 0001127602-19-014668 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,812 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:02 UTC | BrightSphere Investment Group plc BSIG · Entity 156504 | PurchaseCommon Stock, par value $0.001 per share | 14,790,038 | $13.95 | $206,321,030.10 |
DisclosureSEC source: 0001567619-19-005499 · doc1.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Paulson & Co. Inc. Disclosed balance after: 20,000,552 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson & Co."), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.direct: Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:27 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,488 | $18.47 | $27,483.36 |
DisclosureSEC source: 0001127602-19-000700 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,699 F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 20:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Stock, No Par Value | 1,071 | $25.67 | $27,492.57 |
DisclosureSEC source: 0001127602-18-029064 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,211 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:41 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,183 | $23.24 | $27,492.92 |
DisclosureSEC source: 0001127602-18-022655 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,140 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| May 03, 2018 Filed May 4, 2018 21:56 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 14,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016409 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,361 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. Read SEC document |
| May 03, 2018 Filed May 8, 2018 20:36 UTC Amendment | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 13,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-016652 · form4a.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,957 F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. ("Valeant") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the "Annual Meeting"). The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant. F2 · shares: This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 20:54 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | GrantCommon Stock, No Par Value | 1,727 | $15.92 | $27,493.84 |
DisclosureSEC source: 0001127602-18-013758 · form4.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,076 F1 · shares: Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 22:04 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | PurchaseCommon Stock, no par value | 7,066,629 | $15.40 | $108,826,086.60 |
DisclosureSEC source: 0001140361-18-012637 · doc1.xml · nonDerivative · entry 2 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 20,839,035 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.direct: Represent rebalancing transactions between the Funds. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.nature: Represent rebalancing transactions between the Funds. Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 22:04 UTC | Bausch Health Companies Inc. VRX · Entity 4363 | SaleCommon Stock, no par value | 7,066,629 | $15.40 | $108,826,086.60 |
DisclosureSEC source: 0001140361-18-012637 · doc1.xml · nonDerivative · entry 1 Paulson John · CIK 0001394923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Managed Funds Disclosed balance after: 13,772,406 F1 · ownership.direct: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.direct: Represent rebalancing transactions between the Funds. F1 · ownership.nature: John Paulson, the controlling person of Paulson & Co. Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person. F2 · ownership.nature: Represent rebalancing transactions between the Funds. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.